Related Experiment Videos
Retinoids for the prevention of epithelial cancers: current status and future potential
Abstract:
Prevention of epithelial cancers is needed, as the treatment of such cancers in the advanced state has failed. Vitamin A and its structural analogs called retinoids will prevent cancers of the lung, breast, bladder, stomach, and cervix in animals exposed to carcinogens. Synthetic retinoids, offer less toxicity than natural retinoids and may be acceptable to human trials. Identification of a suitable group at risk for an epithelial cancer which might be reasonably expected to benefit from retinoids should precede planning of a clinical trial.
Insights
Vitamin A and retinoids show promise in preventing various epithelial cancers in animal studies. Synthetic retinoids, with lower toxicity, may be suitable for human trials to prevent cancer in at-risk individuals.
Area of Science:
- Oncology
- Nutritional Science
- Chemoprevention
Background:
- Advanced epithelial cancers have poor treatment outcomes.
- Carcinogen exposure increases epithelial cancer risk.
- Vitamin A analogs (retinoids) show potential in cancer prevention.
Purpose of the Study:
- To evaluate the potential of retinoids in preventing epithelial cancers.
- To explore the use of synthetic retinoids for reduced toxicity.
- To identify target populations for future clinical trials.
Main Methods:
- Animal models exposed to carcinogens were used.
- Efficacy of Vitamin A and synthetic retinoids was assessed.
- Toxicity profiles of natural and synthetic retinoids were compared.
Main Results:
- Vitamin A and retinoids demonstrated cancer prevention in multiple animal models (lung, breast, bladder, stomach, cervix).
- Synthetic retinoids exhibited lower toxicity compared to natural forms.
- Retinoids show significant promise for chemoprevention.
Conclusions:
- Retinoids are effective in preventing chemically induced epithelial cancers in animals.
- Synthetic retinoids offer a potentially safer alternative for human application.
- Further research should focus on clinical trials in high-risk human populations.